Sharp Therapeutics Corp.
SHRXF
$3.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.15M | 2.02M | 3.48M | 3.48M | 233.90K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 86.20K | 132.50K | 34.30K | 34.30K | 40.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 29.50K |
| Total Current Assets | 3.24M | 2.15M | 3.52M | 3.52M | 303.90K |
|
|
|||||
| Total Current Assets | 3.24M | 2.15M | 3.52M | 3.52M | 303.90K |
| Net Property, Plant & Equipment | 968.50K | 991.40K | 1.02M | 1.02M | 1.07M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.70K | 16.70K | 16.70K | 16.70K | 16.70K |
| Total Assets | 4.22M | 3.16M | 4.55M | 4.55M | 1.39M |
|
|
|||||
| Total Accounts Payable | 346.80K | 367.20K | 271.70K | 271.70K | 430.90K |
| Total Accrued Expenses | 117.40K | 101.50K | 251.30K | 251.30K | 427.30K |
| Short-term Debt | -- | -- | -- | -- | 13.70M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 48.10K | 42.00K | 36.20K | 36.20K | 31.00K |
| Total Finance Division Other Current Liabilities | 0.00 | 2.04M | 130.70K | 130.70K | 16.50K |
| Total Other Current Liabilities | 0.00 | 2.04M | 130.70K | 130.70K | 16.50K |
| Total Current Liabilities | 512.30K | 2.55M | 689.80K | 689.80K | 14.60M |
|
|
|||||
| Total Current Liabilities | 512.30K | 2.55M | 689.80K | 689.80K | 14.60M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 13.70M |
| Capital Leases | 1.25M | 1.27M | 1.28M | 1.28M | 1.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.76M | 3.82M | 1.97M | 1.97M | 15.90M |
|
|
|||||
| Common Stock & APIC | 25.01M | 22.50M | 22.46M | 22.46M | 5.15M |
| Retained Earnings | -22.58M | -23.14M | -19.89M | -19.89M | -19.66M |
| Treasury Stock & Other | 26.00K | -19.90K | 6.10K | 6.10K | -- |
| Total Common Equity | 2.46M | -662.70K | 2.58M | 2.58M | -14.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.46M | -662.70K | 2.58M | 2.58M | -14.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.46M | -662.70K | 2.58M | 2.58M | -14.51M |
|
|
|||||